Brian Armstrong’s NewLimit Raises $435M for Human Trials

2026-6-4 11:24

NewLimit raised $435M in Series C funding led by Founders Fund to advance its first age-reprogramming drug into human trials. origin »

Bitcoin price in Telegram @btc_price_every_hour

Global Human Trust (GHT) на Currencies.ru

$ 0 (+0.00%)
Объем 24H $0
Изменеия 24h: 0.00 %, 7d: 0.00 %
Cегодня L: $0 - H: $0
Капитализация $0 Rank 99999
Доступно / Всего 0 GHT

trials 435m human newlimit advance fund age-reprogramming